Edition:
India

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

834.95INR
10:21am IST
Change (% chg)

Rs8.80 (+1.07%)
Prev Close
Rs826.15
Open
Rs830.00
Day's High
Rs837.00
Day's Low
Rs829.00
Volume
339,315
Avg. Vol
2,192,049
52-wk High
Rs1,573.60
52-wk Low
Rs818.50

Summary

Name Age Since Current Position

Manju Gupta

2017 Chairman of the Board

Vinita Gupta

49 2013 Chief Executive Officer, Executive Director

Kamal Sharma

67 2013 Executive Vice Chairman of the Board

Ramesh Swaminathan

2015 Chief Financial Officer, Executive Director

Debabrata Chakravorty

2013 President – Global Sourcing & Contract Manufacturing

Fabrice Egros

President - Asia Pacific & Japan

Alok Ghosh

2010 President - Technical Operations

Yugesh Goutam

2016 President - Global Human Resources

Naresh Gupta

President - API & Global TB

Rajender Kamboj

President - Novel Drug Discovery & Development

Cyrus Karkaria

2010 President - Biotechnology

Sunil Makharia

2013 President - Finance

Paul McGarty

President - Lupin Pharmaceuticals Inc., USA

Martin Mercer

President - Latin America

Kurt Nielsen

48 2016 President of Lupin -Somerset, USA

Rajeev Sibal

President - India Region Formulations

Noriaki Tsunoda

President - Kyowa Pharmaceutical Co. Ltd., Japan

Thierry Volle

2015 President - Europe , Middle-East & Africa (EMEA)

Rajvardhan Satam

2008 Compliance Officer, Company Secretary

Nilesh Gupta

2013 Managing Director, Executive Director

Jim Loerop

2017 Chief Corporate Development Officer

Sofia Mumtaz

2016 Head - Pipeline Management & Legal

Jean-Luc Belingard

2015 Non-Executive Independent Director

Dileep Choksi

67 2012 Non-Executive Independent Director

Vijay Kelkar

75 2010 Non-Executive Independent Director

K. Mada

83 Non-Executive Independent Director

R. Shah

86 2005 Non-Executive Independent Director

Richard Zahn

2010 Non-Executive Independent Director

Arvind Bothra

2017 Head - Investor Relations and M&A

Biographies

Name Description

Manju Gupta

Mrs. Manju Deshbandhu Gupta serves as Chairman of the Board of Lupin Limited. Mrs. Gupta is a graduate in arts, She is one of the promoters of the company with a wide business experience.

Vinita Gupta

Ms. Vinita Gupta serves as Chief Executive Officer, Executive Director of Lupin Limited. She is graduate in pharmacy from the University of Mumbai and MBA from J L Kellog Graduate School of Management, Ms. Vinita Gupta has been instrumental in Lupin's forays into the Advanced Markets and heads the Advanced Market business of the company in the markets of USA and Europe. Under her leadership, Lupin has emerged as a global generic player, especially in the US market in addition to becoming a strong player in the pediatric branded market. She is also a Chief Executive Officer Lupin Limitedon the Board of Lupin Ltd.

Kamal Sharma

Dr. Kamal K. Sharma, Ph.D. serves as Executive Vice Chairman of the Board of Lupin Limited, since September 1, 2013. Dr. Kamal K. Sharma is a graduate in chemical engineering from the Indian institute of Technology (IIT), Kanpur, with a post-graduate diploma in industrial management from Jamnalal Bajaj Institute of management Studies, Mumbai, and a Ph.D in economics from IIT, Mumbai. He has also completed an advanced management program from Harvard Business School, Boston. In a career spanning more than three decades, Dr. Sharma has held a range of senior management positions managing projects, corporate development and general management in the pharmaceuticals and chemicals industries.

Ramesh Swaminathan

Mr. Ramesh Swaminathan serves as Chief Financial Officer, Executive Director of Lupin Limited. Mr. Ramesh Swaminathan, with an experience of over 29 years, joined the Company on July 4, 2007, as President - Finance & Planning and is presently designated as Chief Financial Officer and Executive Director. Mr. Ramesh is a member of the Institute of Chartered Accountants of India, the Institute of Cost and Works Accountants of India, the Institute of Company Secretaries of India and the Chartered Institute of Management Accountants, U.K. Mr. Ramesh is Lord Chevening scholar at the UK for Management Studies and has also done his Senior Management Program from INSEAD France. Prior to joining Lupin, he was with Henkel, Germany, as the Regional Financial Controller and has worked with VST Industries, the SPIC group and Standard Chartered Bank.

Debabrata Chakravorty

Fabrice Egros

Alok Ghosh

Yugesh Goutam

Naresh Gupta

Rajender Kamboj

Cyrus Karkaria

Sunil Makharia

Paul McGarty

Martin Mercer

Kurt Nielsen

Dr. Kurt R. Nielsen serves as President of Lupin -Somerset, USA of the company. He has over 20 years of rich experience in creating, managing high growth businesses; research, development and launching new products in the US; managing transactions, business development and Mergers & Acquisitions. Kurt joins Lupin from Sandoz, where he held dual responsibility of being the Global Head of Product Development (a.i.) as well as being the Vice-President of US Product Development, Portfolio and Launch Management for generic and brand products. Having started his pharmaceutical career at Johnson & Johnson, Kurt's previous leadership roles include being the Chief Technology Officer & Senior Vice-President at Catalent Pharma Solutions, responsible for their global R&D efforts; Senior Vice President in-charge of R&D, Technology ops. including Manufacturing & Quality at URL Mutual Pharmaceuticals and being the Executive Director of Generic R&D at TEVA Pharmaceuticals. He holds a Ph.D in Chemistry from the Villanova University and has a BS in Chemistry from theUniversity of Delaware.

Rajeev Sibal

Noriaki Tsunoda

Thierry Volle

Dr. Thierry Volle serves as President - Europe , Middle-East & Africa (EMEA) of the Company. At Lupin, Thierry will be responsible for the Company's growth and development in Europe , Russia & CIS, and Middle-East and African markets. He will be based at Lupin's European headquarters in Zug, Switzerland. Thierry joins Lupin from Vifor Pharma where he was the head of EU & International business operations. Prior to that, he was at Wyeth and worked his way through multiple roles of increasing responsibility in Europe as well as the corporate headquarters in St. Davids, PA. Thierry has extensive international experience in building and growing specialty pharmaceuticals businesses across markets specifically in EMEA, with a focus on business & market development, integration & change management and product portfolio management. He holds a Business diploma from Institut Supérieur de Gestion and a Master's degree in Computer Science from Centre d'études supérieures industrielles- Centrale, Paris and has also completed various Executive Programs at the Harvard School of Public Health , INSEAD and EPFL to name a few.

Rajvardhan Satam

Mr. Rajvardhan V. Satam

Nilesh Gupta

Mr. Nilesh Gupta serves as Managing Director, Executive Director of Lupin Limited. Mr. Nilesh Gupta is a chemical engineer from UDCT, Mumbai, and a graduate with honours from the Wharton School, U.S.A. Mr. Gupta had demonstrated exemplary performance in integrating and leading the diversified portfolio and ably contributed to the growth and profitability of the Company. He directed the IP strategy of the Company towards achieving a niche position for chosen products. Mr. Gupta is a sound business leader and team builder.

Jim Loerop

Sofia Mumtaz

Jean-Luc Belingard

Mr. Jean-Luc Belingard serves as Non-Executive Independent Director of the Company. Mr. Belingard started his career in 1974 in Sales & Marketing with Merck, Sharp and Dohme (France). In 1981, he moved to Merck, Sharp and Dohme (USA) as Senior Director, Promotion Planning. In 1983, he joined F. Hoffman-La Roche, Basel, Switzerland as Associate Director, International Marketing. During 1990-1998, he was Member of the Executive Committee, F. Hoffman-La Roche Ltd. and Chief Executive Officer, Roche Diagnostics, Basel, Switzerland. From 1999 to 2001, he was Chief Executive Officer, BioMerieux-Pierre Fabre, France. During 2002-2010, he was Chairman and Chief Executive Officer, Ipsen Group, France. In 2011, he joined BioMerieux S.A. as Chief Executive Officer and became its Chairman in April 2014. Mr. Belingard has been conferred upon prestigious National Awards viz. ‘Chevalier de I’Ordre National du Merite’ and ‘Chevalier de la Legion d’Honneur’. Presently, Mr. Belingard is Member of the Board of Directors of Laboratory Corporation of America (USA), Stallergenes (France/USA), Transgene (France) and Laboratoire Pierre Fabre, (France). Since 2014, he is Member of the Bill and Melinda Gates Foundation. Since 1988, he is Foreign Trade Advisor to the French Government. He has served as Member of the Board of Directors of several leading corporates in the U.S., France, Germany and Japan, and has been actively involved with various Associations, Institutions and Advisory Boards in different capacities.

Dileep Choksi

Mr. Dileep C. Choksi serves as Non-Executive Independent Director of Lupin Limited., since October 23, 2012. Mr. Dileep C. Choksi is a leading Chartered Accountant, qualified lawyer and a Cost Accountant with over 35 years of experience. His areas of specialisation include tax planning and structuring for domestic and international clients, including expatriates, finalising collaborations and joint ventures, executive advisory and decision support, corporate restructuring with a focus on start-ups, turnaround and change management strategies and analysing tax impact of various instruments. Mr. Choksi advises some of India’s large business houses on various strategic matters and multinational clients on cross border structuring. He has set up C. C. Chokshi Advisors Pvt. Ltd., the activities of which aim to provide complete solutions for all business requirements.

Vijay Kelkar

Dr. Vijay Laxman Kelkar, Ph.D. serves as Non-Executive Independent Director of Lupin Limited. Dr. Vijay Kelkar is a Ph.D. from the University of California at Berkeley, M.S. from the University of Minnesota and B.S. from Pune University. He held senior positions in the Government of India and was Chairman/Member of several high-powered committees, councils, task forces, working groups, set up by different ministries and departments of the Government of India. Dr. Kelkar had delivered lectures at the Universities of California, Pennsylvania, Vanderbilt, Harvard and Cornell in the US and was visiting Professor at the South Asia Institute, Heidelberg University, West Germany and Center for Economic Development and Administration, Government of Nepal. He was a senior faculty member of the Administrative Staff College of India, Hyderabad and Instructor - Microeconomics, University of California, U.S.A. Dr. Kelkar has authored many books, publications and journals on micro and macroeconomics, reforms of union public sector, emerging challenges and on trade policies. In 2011, Dr. Kelkar was conferred ‘Padma Vibhushan’ for his distinguished and exemplary service to the nation.

K. Mada

Dr. K. U. Mada Ph.D. serves as Non-Executive Independent Director of Lupin Limited. Dr. K. U. Mada is an eminent economist and was a development banker. He holds a Ph.D. (Economics) degree from Bombay University and a certificate in financial management from Jamnalal Bajaj Institute, Mumbai. He taught Economics at Jai Hind College, Mumbai, for seven years. Thereafter, he worked for the Reserve Bank of India and Industrial Development Bank of India (IDBI) and held senior positions, including as Executive Director, IDBI, and a stint as chief of a bank. Dr. Mada was Chairman/Member of several committees constituted by lDBI/other financial institutions and the Government of India. He brought out books, including ‘A Journey through Development Banking (2005)’ and published articles in wellknown journals. He represented lDBI as Speaker/participant at several national and international conferences/seminars on economic, corporate and institutional affairs. He was a visiting faculty at management institutes. Dr. Mada was on the boards of corporate entities and all-India financial institutions, including the Management Development Institute, Gurgaon.

R. Shah

Mr. R. A. Shah serves as Non-Executive Independent Director of Lupin Limited. Mr. R. A. Shah is an eminent Solicitor and senior partner of M/s. Crawford Bayley & Company, a leading firm of Solicitors and Advocates in Mumbai. He specialises in a broad spectrum of Corporate Laws in general, with special focus on foreign investments, joint ventures, technology and license agreements, intellectual property rights, mergers and acquisitions, competition law and insider trading regulations. Mr. Shah is a member of the Managing Committee of Bombay Chamber of Commerce and Indo German Chamber of Commerce.

Richard Zahn

Mr. Richard A. Zahn serves as Non-Executive Independent Director of Lupin Limited. Mr. Richard Zahn is a B. S. (Business Administration) with Honors, Kansas State Teachers College, Kansas. He has completed Executive Education with Amos Tuck School, Dartmouth University, Harvard/MIT Program on Negotiation, The Wharton School, University of Pennsylvania, National Association of Corporate Directors - Certificate of Director Education. Mr. Zahn has also completed program in Executive Leadership, Cornell University. Mr. Richard is the Managing Partner of HMJ Global Partners, a corporate governance and not-for-profit public policy advisory group. With more than 30 years of experience in the biotechnology and pharmaceutical industries, he is an established leader and strategist in healthcare research and development, marketing management, managed care, and human resources. He is widely recognised as an insightful speaker on economic and policy issues. Mr. Richard was President of Schering Laboratories, U.S., Director, Schering Corporation and Corporate Vice President of Schering-Plough Corporation, a global researchbased company engaged in the discovery, development,manufacturing and marketing of pharmaceutical, biotechnology and healthcare prescription pharmaceutical marketing arm for Schering-Plough. Mr. Richard spent 20 years at Johnson & Johnson. Mr. Richard has focused his efforts on rural economic development and public policy. He has received several awards for his devoted work towards various organisations and charities with particular focus on health care and minority issues.

Arvind Bothra